Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 open-label single-arm study of recombinant carboxypeptidase G2 for delayed methotrexate elimination in osteosarcoma
CTR20212125Phase 3Active
- Sponsor
- Chongqing Kerun Biopharmaceutical
- Start
- Sep 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of glucarpidase in Methotrexate overdose, sponsored by Chongqing Kerun Biopharmaceutical. Started Sep 2021; status: active.
02
Drugs
glucarpidase
03
Conditions
Methotrexate overdose
Beyond the preview
Go deeper on CTR20212125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212125.